Background illustration for clinical trials search

Leukemia Clinical Trials

Browse 1,316 Leukemia clinical trials enrolling across the United States and Canada. Search by city or state to find one near you.

Filter
1

A Study of Revumenib and Mezigdomide in People With Leukemia

for
Leukemia, Acute Leukemia, Relapse Leukemia, Refractory Leukemia,
Location: Commack NY, Rockville Centre NY, Harrison NY,
Sponsor: Memorial Sloan Kettering Cancer Center

Sex: All

Age: 12+

Code: NCT07356154

Phase1, Phase2, Recruiting

Survivors Uniting for Remote Guided Exercise

for
Cancer,
Location: Fort Collins CO
Sponsor: Colorado State University

Sex: All

Age: 18+

Code: NCT07290309

Recruiting

Venetoclax and Obinutuzumab Followed by Epcoritamab for the Treatment of Untreated Chronic Lymphocytic Leukemia and Small Lymphocytic Lymphoma, LonGEVity Trial

for
Chronic Lymphocytic Leukemia, Small Lymphocytic Lymphoma
Location: Newnan GA, Irvine CA, Duarte CA, Long Beach CA
Sponsor: City of Hope Medical Center

Sex: All

Age: 18+

Code: NCT07218510

Phase2, Recruiting

Study of AZD4512 Monotherapy or in Combination With Anticancer Agents in Participants With Acute Lymphoblastic Leukemia

for
B-cell Acute Lymphoblastic Leukemia (B-ALL)
Location: Toronto, Franklin TN, Chicago IL, Iowa City IA,
Sponsor: AstraZeneca

Sex: All

Age: 12+

Code: NCT07109219

Phase1, Phase2, Recruiting

Phase Ib Study of CD33 FPBMC in Patients With MRD+ AML or MDS

for
Acute Myeloid Leukemia, Myelodysplastic Syndromes,
Location: Charlottesville VA
Sponsor: University of Virginia

Sex: All

Age: 18+

Code: NCT07270978

Phase1, Recruiting

Interested in new trials?

Get alerts for new trials in your area by subscribing now

Subscriber Image

Olutasidenib With Azacitidine Followed by Olutasidenib Maintenance for the Treatment of IDH1-mutated Acute Myeloid Leukemia in Patients With Prior Treatment With Venetoclax Plus a Hypomethylating Agent

for
Acute Myeloid Leukemia
Location: Sacramento CA
Sponsor: University of California, Davis

Sex: All

Age: 18+

Code: NCT07304011

Phase2, Recruiting

Phase I/II Clinical Trial of Axatilimab, a CSF1R Monoclonal Antibody, in Combination With Ruxolitinib as Therapy for Patients With Myelofibrosis (MF) and Chronic Myelomonocytic Leukemia (CMML)

for
Myelofibrosis (MF), Chronic Myelomonocytic Leukemia (CMML)
Location: Houston TX
Sponsor: M.D. Anderson Cancer Center

Sex: All

Age: 18+

Code: NCT07128381

Phase1, Phase2, Recruiting

Imetelstat Combinations in Relapsed AML

for
Relapsed Acute Myeloid Leukemia
Location: New York NY
Sponsor: Douglas Tremblay

Sex: All

Age: 18+

Code: NCT07320235

Phase1, Recruiting

A Phase 1 Trial of CIML NK Cell Infusion for Myeloid Disease Relapse After Hematopoietic Cell Transplantation

for
Acute Myeloid Leukemia, Myelodysplastic Syndromes,
Location: Boston MA
Sponsor: Dana-Farber Cancer Institute

Sex: All

Age: 12+

Code: NCT04024761

Phase1, Recruiting

Testing the Effectiveness of the Anti-cancer Drug, Mirdametinib, in Treating Relapsed, Refractory Chronic Lymphocytic Leukemia

for
Recurrent Chronic Lymphocytic Leukemia,
Location: Boston MA, Chapel Hill NC, Pittsburgh PA, Columbus OH,
Sponsor: National Cancer Institute (NCI)

Sex: All

Age: 18+

Code: NCT07061951

Phase2, Recruiting

Blinatumomab Consolidation in Real World

for
B-Cell Acute Lymphoblastic Leukaemia
Location: Philadelphia PA, Jacksonville FL, Milwaukee WI
Sponsor: Medical College of Wisconsin

Sex: All

Age: 18+

Code: NCT07117136

Recruiting

xDRIVE for Florida-based Cancer Patients

for
Cancer, Neoplams, Refractory, Recurrence, Leukaemia, Lymphoma,
Location: Miami FL
Sponsor: First Ascent Biomedical Inc.

Sex: All

Age: 0+

Code: NCT07167381

Recruiting

Transgene Assay Testing Service of Tumor Samples From Patients Who Received a Bristol-Myers Squibb Manufactured Gene Modified Cell Therapy and Have a Qualifying Second Primary Malignancy

for
Non-Hodgkin Lymphoma, Chronic Lymphocytic Leukaemia,
Location: Dallas TX, Salt Lake City UT
Sponsor: Bristol-Myers Squibb

Sex: All

Age: 0+

Code: NCT06357754

Recruiting

Phase 1 Study of AUTX-703 in Relapsed/Refractory AML and MDS

for
Relapsed Acute Myeloid Leukemia (AML),
Location: Philadelphia PA, Chapel Hill NC, Duarte CA
Sponsor: Auron Therapeutics, Inc.

Sex: All

Age: 18+

Code: NCT06846606

Phase1, Recruiting

Two Step Haplo With Radiation Conditioning

for
Acute Lymphoblastic Leukemia, Acute Myeloid Leukemia,
Location: Philadephia PA
Sponsor: Thomas Jefferson University

Sex: All

Age: 18+

Code: NCT05031897

Phase2, Recruiting

A Multi-Site Break Through Cancer Trial: Targeting Measurable Residual Disease in Patients With Acute Myeloid Leukemia: A Phase 1/2 Study of Tagraxofusp, Azacitidine, and Venetoclax

for
Acute Myeloid Leukaemia (AML), Leukemia, Blood Cancer,
Location: Boston MA
Sponsor: Jacqueline Garcia, MD

Sex: All

Age: 18+

Code: NCT07148180

Phase1, Phase2, Recruiting

A Study to Evaluate the Safety and Efficacy of Tacabrutideg (BGB-16673) Compared to Pirtobrutinib in Adults With Relapsed/Refractory Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma

for
Chronic Lymphocytic Leukemia, Small Lymphocytic Lymphoma
Location: Boston MA, New York NY, Hackensack NJ,
Sponsor: BeOne Medicines

Sex: All

Age: 18+

Code: NCT06973187

Phase3, Recruiting

Studies to Assess Ziftomenib in Combination With Ven+Aza or 7+3 in Patients With Untreated NPM1-m or KMT2A-r AML

for
Acute Myeloid Leukemia (AML)
Location: Worcester MA, Hartford CT, New Haven CT, New York NY,
Sponsor: Kura Oncology, Inc.

Sex: All

Age: 18+

Code: NCT07007312

Phase3, Recruiting

A Study of Fludarabine Dosing in Children and Young Adults With B-cell Acute Lymphoblastic Leukemia

for
B-cell Acute Lymphoblastic Leukemia
Location: New York NY, Philadelphia PA, Cincinnati OH
Sponsor: Memorial Sloan Kettering Cancer Center

Sex: All

Age: 1+

Code: NCT07223021

Phase3, Recruiting

Use of Isatuximab, Dexamethasone and Lenalidomide in a Go-Slow Fashion for Ultra-Frail Patients With Multiple Myeloma

for
Multiple Myeloma, Plasma Cell Leukemia
Location: Salt Lake City UT
Sponsor: University of Utah

Sex: All

Age: 18+

Code: NCT06517017

Phase2, Recruiting

What are clinical trials for leukemia?

Clinical trials for leukemia are research studies designed to evaluate new treatments, therapies, or diagnostic methods for different types of leukemia, a group of cancers that affect the blood and bone marrow. These trials aim to discover more effective ways to treat leukemia, manage its symptoms, and improve patient outcomes. They may involve testing new drugs, combinations of existing treatments, targeted therapies, immunotherapies, or novel approaches like gene therapy.

Why are leukemia clinical trials important?

Leukemia clinical trials are crucial because they drive advancements in treatment by testing new therapies, improving existing ones, and exploring novel approaches to manage and potentially cure the disease. These trials provide essential data on the safety and effectiveness of new treatments, which can lead to better outcomes and fewer side effects compared to current options.

Types of clinical trials for leukemia

Why participate in a leukemia clinical trial

Who can participate in a clinical trial for leukemia?

How to enroll in a leukemia clinical trial